Category Archives
12 Articles

Zenabis – ZENA

Zenabis gets another shot. Again.

Zenabis has experienced several financial gyrations over the past 8 months. They've resulted in a range of impacts to the company: from operations and the business plan, to share price and capital st read more

Zenabis has experienced several financial gyrations over the past 8 months. They've resulted in a range of im read more

$ZENA: On the “Rights” side?

We’ve written lately about some of the travails Zenabis' CEO Andrew Grieve has had to bear:  A (second) refinancing that we pointed out has likely precluded any more of them in the near te read more

We’ve written lately about some of the travails Zenabis' CEO Andrew Grieve has had to bear:  A (sec read more